Atlas Trials

Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast Cancer

Clinical trial NCT00358098 · TERMINATED

Trial details

NCT number
NCT00358098
Sponsor
AHS Cancer Control Alberta
Status
TERMINATED
Study type
OBSERVATIONAL
Metastatic Breast Cancer
Start date
2006-08-01
Primary completion
2013-06-01
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.